Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4564-4572

  Saleh, Maher ^a   Nagaraju, Mahesh ^a   Porciatti, Vittorio ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; RETINA GANGLION CELL; AGING; ANIMAL; DBA MOUSE; DISEASE COURSE; DISEASE MODEL; ELECTRORETINOGRAPHY; FOLLOW UP; NERVE FIBER; OCULOPLETHYSMOGRAPHY; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; RETINA CONE;

AGING; ANIMALS; CONES (RETINA); DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; INTRAOCULAR PRESSURE; MICE; MICE, INBRED DBA; NERVE FIBERS; OPTIC NERVE DISEASES; PHOTIC STIMULATION; RETINAL DISEASES; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 35748954918     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0483     Document Type: Article

References (92)

1. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
2. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
4. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:166-191.
5. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18:39-57.
6. Quigley HA. Glaucoma: macrocosm to microcosm: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2005;46:2662-2670.
7. John SW. Mechanistic insights into glaucoma provided by experimental genetics: the Cogan lecture. Invest Ophthalmol Vis Sci. 2005;46:2649-2661.
8. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol. 2004;15:80-84.
9. Libby RT, Gould DB, Anderson MG, John SW. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet. 2005;6:15-44.
10. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways: a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res. 2005;24:639-662.
11. John SW, Anderson MG, Smith RS. Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J Glaucoma. 1999;8:400-412.
12. Levin LA, Gordon LK. Retinal ganglion cell disorders: types and treatments. Prog Retin Eye Res. 2002;21:465-484.
13. Levkovitch-Verbin H. Animal models of optic nerve diseases. Eye. 2004;18:1066-1074.
14. Lindsey JD, Weinreb RN. Elevated intraocular pressure and transgenic applications in the mouse. J Glaucoma. 2005;14:318-320.
15. Morrison BM, Hof PR, Morrison JH. Determinants of neuronal vulnerability in neurodegenerative diseases. Ann Neurol. 1998;44:S32-44.
16. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci. 2003;8:s1140-1156.
17. Tatton W, Chen D, Chalmers-Redman R, Wheeler L, Nixon R, Tatton N. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv Ophthalmol. 2003;48(suppl 1):S25-S37.
18. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508-518.
19. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
20. Libby RT, Anderson MG, Pang IH, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:637-648.
21. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313-325.
22. Moon JI, Kim IB, Gwon JS, et al. Changes in retinal neuronal populations in the DBA/2J mouse. Cell Tissue Res. 2005;320:51-59.
23. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2002;30:81-85.
24. Zhou X, Li F, Kong L, Tomita H, Li C, Cao W. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem. 2005;280:31240-31248.
25. Inman DM, Sappington RM, Horner PJ, Calkins DJ. Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:986-996.
26. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
27. Maffei L, Fiorentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science. 1981;211:953-955.
28. Porciatti V, Pizzorusso T, Cenni MC, Maffei L. The visual response of retinal ganglion cells is not altered by optic nerve transection in transgenic mice overexpressing Bcl-2. Proc Natl Acad Sci USA. 1996;93:14955-14959.
29. Porciatti V, Saleh M, Nagaraju M. The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2007;48:745-751.
30. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2003;44:1138-1141.
31. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46:4617-4621.
32. Riggs LA, Johnson EP, Schick AML. Electrical responses of the human eye to moving stimulus pattern. Science. 1964;144:567-568.
33. Zrenner E. The physiological basis of the pattern electroretinogram. In: Osborne N, Chader G, eds. Progress in Retinal Research. Oxford, UK: Pergamon Press; 1990:427-464.
34. Hollander H, Bisti S, Maffei L, Hebel R. Electroretinographic responses and retrograde changes of retinal morphology after intracranial optic nerve section: a quantitative analysis in the cat. Exp Brain Res. 1984;55:483-493.
35. Maffei L, Fiorentini A, Bisti S, Hollander H. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res. 1985;59:423-425.
36. Morrone C, Fiorentini A, Bisti S, Porciatti V, Burr DC. Pattern-reversal electroretinogram in response to chromatic stimuli: II. Monkey. Vis Neurosci. 1994;11:873-884.
37. Berardi N, Domenici L, Gravina A, Maffei L. Pattern ERG in rats following section of the optic nerve. Exp Brain Res. 1990;79:539-546.
38. Domenici L, Gravina A, Berardi N, Maffei L. Different effects of intracranial and intraorbital section of the optic nerve on the functional responses of rat retinal ganglion cells. Exp Brain Res. 1991;86:579-584.
39. Chierzi S, Cenni MC, Maffei L, et al. Protection or retinal ganglion cells and preservation of function after optic nerve lesion in bcl-2 transgenic mice. Vision Res. 1998;38:1537-1543.
40. Ratto GM, Bonfanti L, Cenni MC, et al. Retinal ganglion cell anatomy and physiology after section of the optic nerve in mice overexpressing bcl-2. Adv Neurol. 1997;72:87-94.
41. Sieving PA, Steinberg RH. Proximal retinal contribution to the intraretinal 8-Hz pattern ERG of cat. J Neurophysiol. 1987;57:104-120.
42. Baker CL Jr, Hess RR, Olsen BT, Zrenner E. Current source density analysis of linear and non-linear components of the primate electroretinogram. J Physiol. 1988;407:155-176.
43. Hess RF, Baker CL Jr. Human pattern-evoked electroretinogram. J Neurophysiol. 1984;51:939-951.
44. Drasdo N, Thompson DA, Thompson CM, Edwards L. Complementary components and local variations of the pattern electroretinogram. Invest Ophthalmol Vis Sci. 1987;28:158-162.
45. Drasdo N, Thompson DA, Arden GB. A comparison of pattern ERG amplitudes and nuclear layer thickness in different zones of the retina. Clin Vision Sci. 1990;5:415-420.
46. Trimarchi C, Biral G, Domenici L, Porciatti V, Bisti S. The flash- and pattern electroretinogram generators in the cat: a pharmacological approach. Clin Vision Sci. 1990;6:19-24.
47. Viswanathan S, Frishman LJ, Robson JG. The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci. 2000;41:2797-2810.
48. Siliprandi R, Bucci MG, Canella R, Carmignoto G. Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cats. Invest Ophthalmol Vis Sci. 1988;29:558-565.
49. Feghali JG, Jin JC, Odom JV. Effect of short-term intraocular pressure elevation on the rabbit electroretinogram. Invest Ophthalmol Vis Sci. 1991;32:2184-2189.
50. Rossi FM, Pizzorusso T, Porciatti V, Marubio LM, Maffei L, Changeux JP. Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc Natl Acad Sci USA. 2001;98:6453-6458.
51. Porciatti V, Pizzorusso T, Maffei L. The visual physiology of the wild type mouse determined with pattern VEPs. Vision Res. 1999;39:3071-3081.
52. Fraunfelder FT, Burns RP. Acute reversible lens opacity: caused by drugs, cold, anoxia, asphyxia, stress, death and dehydration. Exp Eye Res. 1970;10:19-30.
53. Ridder W 3rd, Nusinowitz S, Heckenlively JR. Causes of cataract development in anesthetized mice. Exp Eye Res. 2002;75:365-370.
54. Remtulla S, Hallett PE. A schematic eye for the mouse, and comparisons with the rat. Vision Res. 1985;25:21-31.
55. Schmucker C, Schaeffel F. A paraxial schematic eye model for the growing C57BL/6 mouse. Vision Res. 2004;44:1857-1867.
56. Lyubarsky AL, Daniele LL, Pugh EN, Jr. From candelas to photoisomerizations in the mouse eye by rhodopsin bleaching in situ and the light-rearing dependence of the major components of the mouse ERG. Vision Res. 2004;44:3235-3251.
57. Smith RS, John SWM, Nishina PM, Sundberg JP. Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. Boca Raton, FL: CRC Press; 2002.
58. Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN. Optic nerve damage in experimental mouse ocular hypertension. Invest Ophthalmol Vis Sci. 2003;44:4321-4330.
59. Mabuchi F, Lindsey JD, Aihara M, Mackey MR, Weinreb RN. Optic nerve damage in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci. 2004;45:1841-1845.
60. Anderson MG, Libby RT, Gould DB, Smith RS, John SW. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci USA. 2005;102:4566-4571.
61. Kocaoglu OP, Ulhorn SR, Hernandez E, et al. Simultaneous fundus imaging and optical coherence tomography of the mouse retina. Invest Ophthalmol Vis Sci. 2007;48:1283-1289.
62. Ogden TE. Nerve fiber layer of the primate retina: thickness and glial content. Vision Res. 1983;23:581-587.
63. Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol. 1999;117:1050-1056.
64. Wang L, Cioffi GA, Cull G, Dong J, Fortune B. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci. 2002;43:1088-1094.
65. Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000;132:476-484.
66. Naskar R, Wissing M, Thanos S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2962-2968.
67. CTNGSG. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:487-497.
68. Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone klotho. Science. 2005;309:1829-1833.
69. Ventura LM, Sorokac N, De Los Santos R, Feuer WJ, Porciatti V. The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest Ophthalmol Vis Sci. 2006;47:3904-3911.
70. Ventura LM, Porciatti V. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ophthalmology. 2005;112:20-27.
71. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1:17-26.
72. Reichstein D, Ren L, Filippopoulos T, Mittag T, Danias J. Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma. Exp Eye Res. 2007;84:13-21.
73. Ward MS, Khoobehi A, Lavik EB, Langer R, Young MJ. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J Pharm Sci. 2007;96:558-568.
74. Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci. 2007;48:1212-1218.
75. Weber AJ, Harman CD. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest Ophthalmol Vis Sci. 2005;46:3197-3207.
76. Neufeld AH, Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist. 2003;9:485-495.
77. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
78. Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (Berl). 2004;107:352-358.
79. Sieving PA, Steinberg RH. Contribution from proximal retina to intraretinal pattern ERG: the M-wave. Invest Ophthalmol Vis Sci. 1985;26:1642-1647.
80. Frishman LJ, Yamamoto F, Bogucka J, Steinberg RH. Light-evoked changes in [K+]o in proximal portion of light-adapted cat retina. J Neurophysiol. 1992;67:1201-1212.
81. Kremmer S, Tolksdorf-Kremmer A, Stodtmeister R. Simultaneous registration of VECP and pattern ERG during artificially raised intraocular pressure (in German). Ophthalmologica. 1995;209:233-241.
82. Artal P, Herreros de Tejada P, Munoz Tedo C, Green DG. Retinal image quality in the rodent eye. Vis Neurosci. 1998;15:597-605.
83. de la Cera EG, Rodriguez G, Llorente L, Schaeffel F, Marcos S. Optical aberrations in the mouse eye. Vision Res. 2006;46:2546-2553.
84. CNTGSG. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:498-505.
85. Nissirios N, Goldblum D, Rohrer K, Mittag T, Danias J. Noninvasive determination of intraocular pressure (IOP) in nonsedated mice of 5 different inbred strains. J Glaucoma. 2007;16:57-61.
86. Avila MY, Carre DA, Stone RA, Civan MM. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest Ophthalmol Vis Sci. 2001;42:1841-1846.
87. John SW, Hagaman JR, MacTaggart TE, Peng L, Smithes O. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci. 1997;38:249-253.
88. Savinova OV, Sugiyama F, Martin JE, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12.
89. Aihara M, Lindsey JD, Weinreb RN. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
90. Mo JS, Anderson MG, Gregory M, et al. By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma. J Exp Med. 2003;197:1335-1344.
91. Schuettauf F, Quinto K, Naskar R, Zurakowski D. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res. 2002;42:2333-2337.
92. Aihara M, Lindsey JD, Weinreb RN. Episcleral venous pressure of mouse eye and effect of body position. Curr Eye Res. 2003;27:355-362.